

Apple Falls, Nebius Surges, Tourmaline Rises
4 snips Sep 9, 2025
Apple's recent iPhone 17 launch had a muted reception, causing its stock to dip 1.5%. Meanwhile, Nebius soared after landing a $19.4 billion deal with Microsoft for AI cloud infrastructure. Tourmaline Bio also saw gains as it announced its $1.4 billion acquisition by Novartis, focusing on innovative treatments for inflammation. Additionally, the mining sector buzzed with excitement over a major merger, boosting Tech Resources' stock. A dynamic mix of tech, biotech, and mining stories kept the market lively!
AI Snips
Chapters
Transcript
Episode notes
iPhone 17 Sparked Tepid Investor Reaction
- Apple unveiled the iPhone 17 lineup with a skinnier Air model and camera and durability upgrades.
- Investors were underwhelmed and shares slipped about 1.7% on the debut.
Nebius Deal Spurs AI Infra Rally
- Nebius (NBIS) rallied after announcing a multiyear deal to give Microsoft dedicated GPU capacity at a new New Jersey data center.
- The arrangement could be worth as much as $19.4 billion and drove a broad AI-infrastructure rally.
Reporter Had To Dig Into Nebius
- Nora Melinda said she had to research Nebius because many listeners hadn't heard of it.
- Her deep dive revealed the company resembles a new Yandex and explained why the Microsoft deal surprised markets.